RecruitingPhase 2NCT06680830
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Sponsor: Neuron23 Inc.
Sun City, AZ · +44 more sites
4 recruiting parkinson's disease studies with a site in Sun City, AZ.
Sponsor: Neuron23 Inc.
Sun City, AZ · +44 more sites
Sponsor: Annovis Bio Inc.
Sun City, AZ · +26 more sites
Sponsor: BlueRock Therapeutics
Scottsdale, AZ · Sun City, AZ · +32 more sites
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Phoenix, AZ · Scottsdale, AZ · Sun City, AZ · +27 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.